Effects of Ticlopidine on Platelet Function and Blood Coagulation

F Violi; C Alessandri; S Frattaroli; A Ghiselli; F Balsano

doi:10.1055/s-0038-1657248

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1982; 48(02): 166-168
DOI: 10.1055/s-0038-1657248

Original Article

Schattauer GmbH Stuttgart

Effects of Ticlopidine on Platelet Function and Blood Coagulation

F Violi

The IVth Clinica Medica, University of Rome, Rome, Italy

,

C Alessandri

The IVth Clinica Medica, University of Rome, Rome, Italy

,

S Frattaroli

The IVth Clinica Medica, University of Rome, Rome, Italy

,

A Ghiselli

The IVth Clinica Medica, University of Rome, Rome, Italy

,

F Balsano

The IVth Clinica Medica, University of Rome, Rome, Italy

› Author Affiliations

Abstract

PDF Download

Summary

A double blind study was performed on 20 atherosclerotic patients. A placebo was administered to one group of 10 patients (group A) and ticlopidine (500 mg/day) was administered to another group of 10 patients (group B) for one month. ADP and collagen-induced platelet aggregation (PA), platelet malondial-deyde (MDA) produced by thrombin stimulation and plasma beta-thromboglobulin (βTG) levels, prothrombin time, activated partial thromboplastin time (APTT) fibrinogen, antithrombin (AT) III, fibrin(ogen) degradation products, alpha₂-antiplasmin and plasminogen were evaluated in both groups before and after treatment. No changes in PA, MDA and βTG were seen in group A. Group B showed a significant decrease of PA, βTG and a significant increase of MDA. No changes on blood coagulation data were seen in either group. This study suggests that ticlopidine is able to inhibit platelet function in vivo.

Keywords

Blood coagulation - Platelet function - Ticlopidine

PDF (474 kb)

References

References
1 Ashida SI, Abiko Y. Mode of action of ticlopidine in inhibition of platelet aggregation in rat. Thromb Haemostas 1979; 41: 436-449
2 Thébault JJ, Blatrix CE, Blanchard JF, Panak EH. Effects of ticlopidine, a new platelet aggregation inhibitor. Clin Pharmacol Ther 1975; 18: 485-490
3 Johnson M, Walton PL, Cotton RC, Strachan CJL. Pharmacological evaluation of ticlopidine, a novel inhibitor of platelet function. Thromb Haemostas 1977; 38: 64 (Abstr.).
4 Lagarde M, Ggazi I, Dechavanne M. Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production. Prostaglandins Med 1979; 2: 440-443
5 Bonne C, Martin B, Regnault F. Hypothetic mechanism of ticlopidine induced hypersensitivity to PGE₁ in rat platelets. Thromb Res 1981; 21: 157-164
6 Bruno JJ, Yang D, Taylor LA, Feamster C. Role of Platelet cAMP and prostaglandin synthesis in platelet aggregation inhibition by ticlopidine hydrochloride. Thromb Haemostas 1981; 46: 66 (Abstr.).
7 Lee M, Paton RC, Ruan C. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets. VIII Intern Congr on Thrombosis and Haemostasis, Toronto, July 11-18 1981 (Abstr.).
8 O'Brien JR, Etherington MD, Shuttleworth RO. Ticlopidine an antiplatelet drug: effects in human volunteers. Thromb Res 1978; 13: 245-254
9 Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202
10 Friberger P, Knor M, Gustavson S, Aurell L, Claeson G. Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis 1978; 7: 138-145
11 Bom GVR. Platelet aggregation by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
12 Stuart MJ, Murphy S, Oski FA. A simple nonradioisotope technic for the determination of platelet life-span. N Engl J Med 1975; 292: 1310-1313
13 Ludlam CA, Cash JD. Studies on the liberation of beta-thromboglobulin from human platelets in vitro. Br J Haematol 1976; 33: 239-247
14 Renner C, Guilmet D, Curtet M. Le ticlopidine en chirurgie cardiaque avec circulation extra-corporelle. Nouv Presse Med 1980; 9: 3249-3251
15 Ban I, Shionoya Y, Nekate K, Hirai M, Keway S. A study on the effects of ticlopidine (DE-4160) for suppression of aggregation of platelets and upon the factors of blood coagulation and fibrinolysis and on the results of therapy with it for patients with peripheral vascular diseases. Nippon Rinsho 1978; 55: 2187-2194
16 Lecrubier C, Conard J, Samama M, Bousser MG. Essay randomized d'un nouvel agent anti-aggregant le ticlopidine. Therapie 1977; 32: 189
17 Steward AMetz. Anti-Inflammatory agents as inhibitors of prostaglandin synthesis in man. Med Clin North Am 1981; 65: 713-757
18 Driot F, Vallee E. Prostaglandin metabolism and mechanism of action of ticlopidine. V. International Conference Prostaglandins. (Abstr.). Florence, May 18-21, 1982: 196
19 Vincent JE, Zijlstra FJ, von de Veedonk MAM, Bonta IL. The effect of ticlopidine on the aggregation of rat blood platelets and on the formation of metabolites of arachidonic acid and 8, 11, 14 eicosatrienoic acid in rat platelets during aggregation and in the rat kidney. V. International Conference Prostaglandins. 197 (Abstr.). Florence, May 18-21, 1982